Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |